Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Rebecca Shatsky

Breast Oncology · UCSD

View

Dr. Robert Bast

Breast Oncology · MD Anderson Cancer Center

View

Dr. Sara Tolaney

Breast Oncology · Dana-Farber Cancer Institute

View

Dr. Jason Mouabbi

Breast Oncology · MD Anderson Cancer Center

View

Dr. Matthew Kurian

Breast Oncology · St Elizabeth Healthcare

View

Dr. Sarah Premji

Breast Oncology

View

Dr. Roberto Leon-Ferre

Breast Oncology · Mayo Clinic College of Medicine

View

Dr. Allison Kurian

Breast Oncology · SU

View

Dr. Minhtri Nguyen

Breast Oncology · Advisor

View

Dr. Neil Iyengar

Breast Oncology · Emory University

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    NLDr. Nerea Lopetegui-Lia
    Leading Voice

    Dr. Nerea Lopetegui-Lia

    Medical Oncology · Breast Oncology
    The Ohio State University Wexner Medical Center
    drnerealopeteguilia
    Columbus, OH

    Research

    The Reply

    2026

    Via The American journal of medicine

    Research

    Physical Diagnosis for Cost-Effective Care: The Case of Painless Zoster

    2025

    Via The American journal of medicine

    Research

    Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study

    2025

    Via Journal for immunotherapy of cancer

    Research

    Characterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study

    2024

    Via Cancer

    Research

    Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers

    2024

    Via Annals of oncology

    Research

    Real-world outcomes of patients with resected stage III melanoma treated with adjuvant therapies

    2024

    Via Cancer medicine

    Research

    Current and Novel Treatment Options in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer

    2024

    Via JCO oncology practice

    Research

    Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histology

    2024

    Via ESMO open

    Research

    Comparison of real-world outcomes following immunotherapy in recurrent or metastatic head and neck squamous cell carcinoma with outcomes of randomized controlled trials

    2023

    Via Head & neck

    Research

    Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium

    2023

    Via Journal of clinical oncology

    Research

    Immunotherapy response in patients with cutaneous squamous cell carcinoma of head and neck with cranial nerve involvement

    2023

    Via Head & neck

    Research

    Toxicity Profile of Chimeric Antigen Receptor T-Cell and Bispecific Antibody Therapies in Multiple Myeloma: Pathogenesis, Prevention and Management

    2023

    Via Current oncology

    Research

    Locoregional recurrence in triple negative breast cancer: past, present, and future

    2023

    Via Expert review of anticancer therapy

    Research

    Tumor infiltrating lymphocytes for breast cancer patient stratification and selection of patients likely to respond to checkpoint inhibitor based immunotherapy

    2022

    Via Journal for immunotherapy of cancer

    Research

    EGFR-mutated advanced lung cancer. Data from a single institution, the Hospital of Leon, in Spain

    2022

    Via Journal of oncology pharmacy practice